Answers are grounded in this paper and cite their sources.
Retrospective observational study reveals that integrating clinical decision support into workflows improves pathway adherence, highlighting tools that support value-based cancer care.
As value-based oncology care gains traction, health practices and providers on the frontlines of care delivery increasingly rely on technological solutions that enable and support favorable performance across a dynamic array of alternative payment models. Successful participation requires a values-based transformation, a key component of which includes practice alignment with evidence-based pathways, which prioritizes the highest-quality treatment options over lower-value, clinically equivalent regimens. In this retrospective, observational, real-world study of treatment selection patterns across American Oncology Network medical oncologists, we analyze pathway adherence rates before and after a pilot project where Evolent level 1 pathways were integrated into Flatiron Assist, an electronic health record-embedded clinical decision support tool in OncoEMR. Results suggest that integrating evidence-based pathways into ordering workflows may improve adherence by providing clinicians with just-in-time clinical and financial insights for optimal treatment decisions.
No takes yet. Share an insight, caveat, or question.
Bolha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: